Conclusion : Single-agent bendamustine is an active treatment in patients with MBC independent of the previous treatment.The low toxicity profile favors its use as a single agent.

• 苯达莫司汀单药治疗MBC具有疗效，而其低毒性的特性支持其采用单药治疗。